Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis

Modern Pathology

Volumn 26, Issue 5, 2013, Pages 665-676

  Matoso, Andres ^a,b   Mukkada, Vincent A ^b   Lu, Shaolei ^a   Monahan, Renee ^a   Cleveland, Kelly ^a   Noble, Lelia ^a   Mangray, Shamlal ^a   Resnick, Murray B ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

ALOX15; CRISP3; eosinophilic esophagitis; FLG; immunohistochemistry; SLURP1; TNFAIP6

Indexed keywords

BLOOD CLOTTING FACTOR 6; CYSTEINE SECRETORY RICH PROTEIN 3; FILAGGRIN; GROWTH FACTOR; SECRETORY PROTEIN; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MICROARRAY ANALYSIS; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; UPREGULATION;

EID: 84877028770     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.41     Document Type: Article

References (32)

1. Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995;109:1503-1512.
2. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2004;351:940-941.
3. Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc 2004; 59:355-361.
4. Mueller S, Neureiter D, Aigner T, et al. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology 2008;53:676-684.
5. Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007;102:2627-2632.
6. Markowitz JE, Spergel JM, Ruchelli E, et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003;98:777-782.
7. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116: 536-547.
8. Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007;120:1292-1300.
9. Lu S, Mukkada VA, Mangray S, et al. MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One 2012;7: e40676.
10. Mishra A, Hogan SP, Brandt EB, et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002;168:2464-2469.
11. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003;125:1419-1427.
12. Bhattacharya B, Carlsten J, Sabo E, et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 2007;38:1744-1753.
13. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128: 3-20; e26; quiz 21-22.
14. Resnick MB, Sabo E, Meitner PA, et al. Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut 2006;55:1717-1724.
15. Adcock IM, Ito K, Barnes PJ. Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 2004;1:247-254.
16. Chu HW, Balzar S, Westcott JY, et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 2002;32:1558-1565.
17. Hajek AR, Lindley AR, Favoreto Jr S, et al. 12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels. J Allergy Clin Immunol 2008;122:e633.
18. Rong S, Cao Q, Liu M, et al. Macrophage 12/15 lipoxigenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. J Lipid Re 2012;53:686-695.
19. Wu MY, Lin TH, Chiu YC, et al. Involvement of 15-lipoxigenase in the inflammatory arthritis. J Cell Biochem 2012;113:2279-2289.
20. Il Lee S, Zuo X, Shureiqi I. 15-Lipoxigenase-1 as tumor suppressor gene in colon cancer: is the veredict in? Cancer Metastasis Rev 2011;30:491.
21. Milner CN, Day AJ. TSG-6 a multifunctional protein associated with inflammation. J Cell Sci 2003;116: 1863-18673.
22. Morar N, Cookson WO, Harper JI, et al. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007;127:1667-1672.
23. Rodriguez E, Baurecht H, Herberich E, et al. Metaanalysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009;123:e1367.
24. Narumoto O, Horiguchi K, Horiguchi S, et al. Down-regulation of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), an endogenous allosteric alpha7 nicotinic acetylcholine receptor modulator, in murine and human asthmatic conditions. Biochem Biophys Res Commun 2010;398:713-718.
25. Udby L, Bjartell A, Malm J, et al. Characterization and localization of cysteine-rich secretory protein 3 (CRISP-3) in the human male reproductive tract. J Androl 2005;26:333-342.
26. Udby L, Calafat J, Sorensen OE, et al. Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils. J Leukoc Biol 2002;72:462-469.
27. Lee TH, Lee GW, Ziff EB, et al. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol 1990;10:1982-1988.
28. Feng P, Liau G. Identification of a novel serum and growth factor-inducible gene in vascular smooth muscle cells. J Biol Chem 1993;268:21453.
29. Bardos T, Kamath RV, Mikecz K, et al. Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis. Am J Pathol 2001; 159:1711-1721.
30. Oh JY, Roddy GW, Choi H, et al. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA 2010;107:16875-16880.
31. Mastrangeli R, Donini S, Kelton CA, et al. ARS component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda. Eur J Dermatol 2003;13:560-570.
32. Udby L, Cowland JB, Johnsen AH, et al. An ELISA for SGP28/CRISP-3, a cysteine-rich secretory protein in human neutrophils, plasma, and exocrine secretions. J Immunol Methods 2002;263:43-55.